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The European Respiratory Society (ERS) Interna-
tional Congress will take place from September 
28 to October 2, 2019, in Madrid, Spain, and 
as every year, the rich and diverse programme 
will be full of opportunities for ERS Early Career 
Members (ECMs). Alongside all the outstanding 
scientific sessions, which are aimed at physicians, 
physician- researchers and basic researchers in all 
fields related to pulmonary medicine, the Early 
Career Member Committee (ECMC) also organises 
several sessions dedicated to the professional 
development of ECMs.
Accordingly, every year the ECMC organises an 
ECM Session (Tuesday, October 1, from 14:45 to 
16:45). This session is specially developed to fit the 
needs of ECMs, and to provide useful information on 
topics related to career development, fellowships, 
and tips and tricks on how to become more involved 
in the ERS [1]. This year’s session will be focused on 
“Effective communication of your science”. Effective 
communication is part of the everyday life for each 
physician, scientist or allied respiratory professional, 
be it communicating scientific advancements 
in diagnostics or therapies to patients, giving 
presentations at conferences or even writing papers 
and proposals. In addition, proper and correct 
communication of scientific facts to the general 
public becomes increasingly important in a world of 
social media and so-called fake news. Furthermore, 
defining measures for effective public outreach is a 
prerequisite for virtually all successful future grant 
applications; thus, scientists and clinicians should 
be trained early on in this aspect. The ECM session 
will provide two presentations on:
●● making yourself and your science memorable 
at the congress
●● strategies to effectively communicate science 
to patients and the wider public
The presentations will be followed by a panel 
discussion with the speakers. During the ECM 
session, the ECMC chair Lieuwe Bos will give an 
overview of what the ECMC can do for you and how 
you can get involved in tasks that are available to 
the ECMs. These presentations will be followed by 
a networking event that provides you with the ideal 
opportunity to meet and interact with fellow ECMs 
while enjoying a drink and some tapas.
Excellent learning and development 
opportunities for ECMs are also offered by 
Professional Development Workshops. These 
aim to provide participants with practical tips and 
guidelines on how to use new skills and knowledge, 
and apply them in a practical setting. The list of 
workshops can be found in the programme on the 
Congress website (https://erscongress.org/) and 
you usually need to register online in advance. In 
particular, we would like to draw attention to the 
workshop “Ethical issues in clinical respiratory 
research – where to draw the line?” that is 
organised by the ECMC. Expert speakers will lead 
a discussion on not only scientific advances but 
also ethical considerations that need to be taken 
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into account by focusing on two novel technologies: 
clustered regularly interspaced short palindromic 
repeats (CRISPR)/CRISPR-associated protein 9 
(Cas9) system-based genome editing and the use 
of (modified) stem cell therapies. CRISPR/Cas9 is 
a bacterial protein–RNA complex. It consists of 
an exonuclease introducing double-strand DNA 
breaks, which is the Cas9 protein, and a guide RNA 
that specifically directs the latter to the location of 
interest in the genome [2]. Thus, after the induction 
of a double-strand break an additionally supplied 
(modified) gene construct can be incorporated into 
the DNA by homologous recombination. Thereby, 
the CRISPR/Cas9 system represents an easy-to-
use molecular tool that is able to delete entire 
genes, to insert super-exon donors to activate 
gene expression or even to edit single base pairs 
to correct mutations, and can basically be handled 
by every skilled researcher in every laboratory [3]. 
Accordingly, it is currently being heavily investigated 
for its potential in the treatment of monogenetic 
lung diseases, such as α1-antitrypsin deficiency or 
cystic fibrosis [4, 5]. Albeit that the CRISPR/Cas9 
genome modification technology seems very 
promising, it has to be noted that its safety and 
potential off-target effects, especially for treating 
human disease, have not yet been clarified.
Thus, in the first part of this course, an 
experienced pulmonary researcher will describe 
the tremendous potential associated with the 
CRISPR/Cas9 technology [5] but will also inform 
the audience about current knowledge gaps and 
putative problems. This will be followed by a talk by 
an expert on bioethics, focusing on the bioethical 
considerations that should be taken into account 
when working with this new technology [6].
In the second part of the workshop, an expert 
in stem cell therapies, and the production and 
application of human stem cells [7] will describe 
the potential of those cells for therapy and discuss 
current gaps in knowledge and pitfalls. Again, 
this will be followed by a talk pointing out ethical 
pitfalls and points of care when developing stem-
cell based therapies [8]. Both parts will be followed 
by interactive group discussions, with pro/con 
debates and discussions of examples brought up by 
participants. Considering the recent heated debate 
sparked by the work of He Jiankui of the Southern 
University of Science and Technology in Shenzhen, 
China, who claimed to have altered the genomes 
of twin baby girls born in November to make the 
children’s cells resistant to infection by HIV, this 
workshop is particularly topical, and covers important 
scientific and ethical questions in an interactive way 
that will favour audience participation and discussion 
of different points of view.
In summary, the ERS Congress offers various 
possibilities for ECMs to proceed in their professional 
development, besides presenting their data and 
meeting with experts in the field. The ECMC is 
looking forward to meeting you in Madrid!
ERS fellowship 
opportunities for ECMs: 
upcoming deadlines
Alongside organising career developmental sessions 
at the Congress, the ERS also provides a wide variety 
of fellowships to foster individual professional 
advancement of ECMs. These fellowships provide 
a unique opportunity to young researchers and 
clinicians to expand their knowledge in another 
institution within Europe. Thereby, the ERS offers 
different types of grants depending on the duration 
of the fellowship. Specifically, the next deadlines for 
the Short-Term Research Fellowships (1–3 months’ 
duration) will be on October 1, 2019, and on April 1, 
2020. For longer periods, ERS offers the Long-Term 
Research Fellowships (from 6 months to up 1 year). 
The call deadline will be during January 2020.
The Clinical Training Fellowships provide the 
opportunity for qualified clinicians to expand their 
expertise in other techniques in a host institution 
for up to 6 months. There are two calls per year, next 
deadlines being October 1, 2019, and April 1, 2020.
ERS also hopes to launch further fellowships later 
in 2019, which will all be published at https://www.
ersnet.org/professional-development/fellowships.
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